about
Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamilyOxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological roleCrystal Structure of Perakine Reductase, Founding Member of a Novel Aldo-Keto Reductase (AKR) Subfamily That Undergoes Unique Conformational Changes during NADPH BindingStructure of the His269Arg mutant of the rat aldose reductase-like protein AKR1B14 complexed with NADPHPartial inhibition of aldose reductase by nitazoxanide and its molecular basisAldo-Keto Reductases 1B in Adrenal Cortex PhysiologyGeneration and biological activities of oxidized phospholipidsMechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseFormation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective EffectsSpecies used for drug testing reveal different inhibition susceptibility for 17beta-hydroxysteroid dehydrogenase type 1Structural basis for substrate specificity in human monomeric carbonyl reductasesElevated expression of AKR1C3 increases resistance of cancer cells to ionizing radiation via modulation of oxidative stressCatalytic mechanism and substrate specificity of the beta-subunit of the voltage-gated potassium channelMethyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosisTissue distribution, ontogeny, and chemical induction of aldo-keto reductases in miceThe Role of Human Aldo-Keto Reductases in the Metabolic Activation and Detoxication of Polycyclic Aromatic Hydrocarbons: Interconversion of PAH Catechols and PAH o-QuinonesThe influence of diesel exhaust on polycyclic aromatic hydrocarbon-induced DNA damage, gene expression, and tumor initiation in Sencar mice in vivoAflatoxin B1 metabolismAnalogs of the RSK inhibitor SL0101: optimization of in vitro biological stability.Insights into the gene expression profile of uncultivable hemotrophic Mycoplasma suis during acute infection, obtained using proteome analysis.Integration of steroid research: perspectives on environment factors, homeostasis in health, and disease treatment.Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesisAldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.Environmental sensing and response genes in cnidaria: the chemical defensome in the sea anemone Nematostella vectensis.Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells.Identification of a gene signature of a pre-transformation process by senescence evasion in normal human epidermal keratinocytes.Semi-rational engineering of a thermostable aldo-keto reductase from Thermotoga maritima for synthesis of enantiopure ethyl-2-hydroxy-4-phenylbutyrate (EHPB)The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) geneProteome analysis of maize seeds: the effect of artificial ageing.Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphomaRole of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization.Nanoparticle growth and surface chemistry changes in cell-conditioned culture medium.Insights into the distinguishing stress-induced cytotoxicity of chiral gold nanoclusters and the relationship with GSTP1.Transcriptomic and proteomic analysis of a compatible tomato-aphid interaction reveals a predominant salicylic acid-dependent plant response.Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds.Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde.Novel molecular targets of Azadirachta indica associated with inhibition of tumor growth in prostate cancer.AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.Induction of a unique isoform of the NCOA7 oxidation resistance gene by interferon β-1b.Quantitative evaluation of aldo-keto reductase expression in hepatocellular carcinoma (HCC) cell lines.
P2860
Q24323295-F9D56772-1E6B-4723-8915-8ECA5A75D737Q26747100-5FD165C6-0F6D-46AA-82B8-17BFE8C4049AQ27677286-1A4D5172-04D5-48F8-B13B-A0E8FAD84144Q27678537-1D2B8C0F-73EE-47A9-A340-245092683C72Q27681971-4EAE87B0-ABEB-42E4-99AB-24883D34E524Q28078668-FB7B604C-45DC-491D-AC24-85785E0B8CAAQ28389691-3F150CF4-A30C-4D44-8900-F08C1FD35331Q28394732-EC243687-EE39-4C1E-B36E-E4D3E2EBFDA4Q28468284-E3E36DDB-9EF8-411A-B47B-6AE72AB8D675Q28474296-914CB6E4-E43D-4969-8C54-F56CE1F8AAA7Q28476175-711A6D00-2F22-4564-911D-980145E322F9Q28545132-250B1C61-37BD-499E-8F4C-E172D91AA497Q28566084-8104CE1E-9ECF-48C5-A845-91E0CCE62691Q28658683-548D0108-86E6-4F98-BFD1-67755C861675Q28677003-1C319E7C-AD55-4F1D-A115-062009B623C1Q28712007-6F9C8947-A8A4-47B4-81A7-AB7EFA5E1B54Q28757348-E0193A85-82AA-428E-B286-585288E44872Q30230999-C9B38C95-4BDD-461A-A3C8-45F0F9520052Q30419492-CE649D57-680F-42BA-B904-BAFFCD96DE9DQ30506460-A9C6B2E6-0ECF-4CB3-A97E-8792B667B4F5Q33559411-274E8E9D-B89B-4EF2-BBE9-A8C08FFE349DQ33580721-859CB33A-DD1F-4B17-8927-0B2E9B2505A3Q33600379-91C29380-767C-4786-A69D-423E5CEB5CC5Q33609122-E126900E-A329-4DCF-81C3-96DC4360371AQ33773197-D12EB008-3B11-4DA7-AC08-05954C1C1B08Q33786391-04491B53-A894-428F-B324-95D753E4FAC0Q33822491-069D3ACF-0DA9-45B0-90B0-703BE64F6194Q33870243-BE180F45-D1C3-4876-A317-1CAD811B8A98Q33943614-97E6D7B4-F29F-41D6-BE9E-9B2F7FBD0E8CQ34062500-39A5EFCE-85BC-4598-AD19-1732F0C6F8CDQ34400600-5D4DA745-0649-4CBA-8F54-9FC6BDE4100EQ34768825-29687777-C0A9-4CC0-B6CE-61A6829914C1Q34785231-2A3A02A7-53A9-4D60-8EB9-C077CA8C2404Q34878167-28E6D9A8-A26C-4613-89D3-5D26DC80DB91Q35011881-7B84206D-A0F4-435D-9ECF-651E264E0479Q35012097-7060B896-2FAF-40A4-B6FD-238C6E0DD90BQ35130059-706361A9-D40A-4F79-AB36-80E08D663792Q35141326-051949C2-CB36-4772-B76E-AE4FF3E3C0EDQ35148941-4F4E9B14-71DC-44C1-803C-65F5B833CD5EQ35171770-027A5EF6-FA9E-4E3A-9F13-C75C646EDDA6
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Aldo-keto reductases and bioactivation/detoxication.
@ast
Aldo-keto reductases and bioactivation/detoxication.
@en
type
label
Aldo-keto reductases and bioactivation/detoxication.
@ast
Aldo-keto reductases and bioactivation/detoxication.
@en
prefLabel
Aldo-keto reductases and bioactivation/detoxication.
@ast
Aldo-keto reductases and bioactivation/detoxication.
@en
P1476
Aldo-keto reductases and bioactivation/detoxication
@en
P2093
P304
P356
10.1146/ANNUREV.PHARMTOX.47.120505.105337
P577
2007-01-01T00:00:00Z